Zimbabwe has declined a significant US health deal worth $367m (272 million pounds) spanning five years over Washington's request for sensitive information.
This rejection was revealed after a official document dated December was disclosed, indicating that President Emmerson Mnangagwa deemed the deal was "lopsided".
An official spokesman has since stated that the US was demanding access to biological samples for research and commercial purposes while was unwilling to share the resulting advantages from future medical innovations.
"We will now turn to the difficult and regrettable task of scaling back our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had donated more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged more talks to reach a agreement acceptable to all parties so the nation's critical HIV programme can proceed.
Broader Implications
Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a high court blocked a related health funding agreement following concerns were raised about the safety of citizens' medical information.
After returning to office recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral deals to boost openness and accountability.
Based on statements, Sixteen nations in Africa have to date agreed to similar agreements, representing over $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded programmes," Tremont commented.
However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data for a long time, without any equivalent promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"Put simply, our country would provide the raw materials for medical research without any assurance that the final treatments would be available to our citizens if a new pandemic emerge."
National Interest and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting systems previously established via the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to manage future pandemics.
"This system is designed to guarantee that when a country provides its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to develop them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage continued discussions with our US partners on how future co-operation might be designed in a way that honours the sovereignty and interests of both nations."
Medical Community Response
A leading public health body said it understood the official position, but suggested that negotiations must proceed since a large portion of the nation's HIV programmes relied on international support.
"If specific concerns arise, such as those relating to information security or implementation frameworks, these can often be resolved via detailed discussion and mutually agreed protections," the group said.
The situation underscores the ongoing debate between accepting vital international aid and protecting a country's data in an ever more interconnected world.